6 employees
Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.
2018
Stingray Therapeutics raised undisclosed on August 15, 2021
Investors: Propel(x)
Stingray Therapeutics raised undisclosed on October 1, 2020
Investors: Newchip